Back
Janux Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
JANX
Janux Therapeutics, Inc.
Last Price:
$13.59
Seasonality Move:
-11.9%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Janux Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.89 | Buy |
| 20-day SMA: | 13.58 | Buy |
| 50-day SMA: | 13.71 | Buy |
| 200-day SMA: | 21.58 | Sell |
| 8-day EMA: | 13.92 | Buy |
| 20-day EMA: | 13.76 | Buy |
| 50-day EMA: | 14.72 | Sell |
| 200-day EMA: | 21.56 | Sell |
Janux Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 54 | Buy |
| Chaikin Money Flow: | 418758 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.01 - 13.91) | Buy |
| Bollinger Bands (100): | (11.77 - 25.75) | Sell |
Janux Therapeutics, Inc. Technical Analysis
| Feb 26 | Feb 27 | Mar 2 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 9 | Mar 10 | Mar 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 26 | 27 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Janux Therapeutics, Inc. Stock
Is Janux Therapeutics, Inc. Stock a Buy?
-
Janux Therapeutics, Inc. share price is 14.08 while JANX 8-day simple moving average is 13.89, which is a Buy signal.
-
The stock price of JANX is 14.08 while Janux Therapeutics, Inc. 20-day SMA is 13.58, which makes it a Buy.
-
Janux Therapeutics, Inc. 50-day simple moving average is 13.71 while JANX share price is 14.08, making it a Buy technically.
-
JANX stock price is 14.08 and Janux Therapeutics, Inc. 200-day simple moving average is 21.58, creating a Sell signal.
JANX Technical Analysis vs Fundamental Analysis
Sell
30
Janux Therapeutics, Inc. (JANX)
is a Sell
Is Janux Therapeutics, Inc. a Buy or a Sell?
-
Janux Therapeutics, Inc. stock is rated a SellThe current Janux Therapeutics, Inc. [JANX] share price is $14.08. The Score for JANX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Janux Therapeutics, Inc. Stock Info
Market Cap:
856.5M
Price in USD:
14.08
Share Volume:
565K
Janux Therapeutics, Inc. 52-Week Range
52-Week High:
35.34
52-Week Low:
12.12
Sell
30
Janux Therapeutics, Inc. (JANX)
is a Sell
Janux Therapeutics, Inc. Share Price Forecast
-
What is the Janux Therapeutics, Inc. stock price today?The Janux Therapeutics, Inc. stock price is 14.08 USD today.
-
Will JANX stock go up or go down?Janux Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Janux Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics, Inc. is overvalued.
Is Janux Therapeutics, Inc. Stock a Buy?
-
Janux Therapeutics, Inc. share price is 14.08 while JANX 8-day exponential moving average is 13.92, which is a Buy signal.
-
The stock price of JANX is 14.08 while Janux Therapeutics, Inc. 20-day EMA is 13.76, which makes it a Buy.
-
Janux Therapeutics, Inc. 50-day exponential moving average is 14.72 while JANX share price is 14.08, making it a Sell technically.
-
JANX stock price is 14.08 and Janux Therapeutics, Inc. 200-day simple moving average is 21.56, creating a Sell signal.
Fundamental Analysis of Janux Therapeutics, Inc.
Is Janux Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.05 per share, a decrease this year of $0.62 per share, and a decrease next year of $0.90 per share.
Technical Analysis of Janux Therapeutics, Inc.
Should I short Janux Therapeutics, Inc. stock?
-
JANX Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting Janux Therapeutics, Inc. is a Buy
-
Janux Therapeutics, Inc. Relative Strength Index (RSI) is 54, which suggest Janux Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Janux Therapeutics, Inc. is (13.01 - 13.91), which suggest Janux Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Janux Therapeutics, Inc. is (11.77 - 25.75), which suggest Janux Therapeutics, Inc. is a Sell
* Janux Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.